以上内容来自Benzinga Earnings专栏,原文如下:
BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.00) per share which beat the analyst consensus estimate of $(0.05) by 98 percent. The company reported quarterly sales of $4.94 million which missed the analyst consensus estimate of $5.29 million by 6.57 percent.
精彩评论